Drug Trial Radar · NCT01428661
Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Jun 19, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
507
Actual
Start
Sep 2011
Primary completion
Jan 2013
Study completion May 2013
Sponsor
- Lead sponsor
- Vanda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Sep 5, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of an 8-week double-masked treatment of tasimelteon or placebo in male and female subjects with Major Depressive Disorder.
Conditions
- Major Depressive Disorder
Interventions
tasimelteonDrug
20 mg once daily
placeboDrug
once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Endpoint at Week 8 Using the Total Score of the Hamilton Depression Rating Scale (HAM-D)Time frame: 8 weeks
Locations
40 sites in 1 country. Site status is shown where the registry gives one.
Vanda Investigational Site
Garden Grove, California
Vanda Investigational Site
Irvine, California
Vanda Investigational Site
Los Alamitos, California
Vanda Investigational Site
Oakland, California
Vanda Investigational Site
Oceanside, California
Vanda Investigational Site
San Diego, California
Vanda Investigational Site
Sherman Oaks, California
Vanda Investigational Site
Torrance, California
Vanda Investigational Site
Denver, Colorado
Vanda Investigational Site
Bradenton, Florida
Vanda Investigational Site
Jacksonville, Florida
Vanda Investigational Site
Maitland, Florida
Vanda Investigational Site
North Miami, Florida
Vanda Investigational Site
Orlando, Florida
Vanda Investigational Site
Atlanta, Georgia
Vanda Investigational Site
Atlanta, Georgia
Vanda Investigational Site
Chicago, Illinois
Vanda Investigational Site
Joliet, Illinois
Vanda Investigational Site
Prairie Village, Kansas
Vanda Investigational Site
Baltimore, Maryland
Vanda Investigational Site
Boston, Massachusetts
Vanda Investigational Site
Omaha, Nebraska
Vanda Investigational Site
Las Vegas, Nevada
Vanda Investigational Site
Toms River, New Jersey
Vanda Investigational Site
Willingboro, New Jersey
Vanda Investigational Site
Brooklyn, New York
Vanda Investigational Site
Mount Kisco, New York
Vanda Investigational Site
New York, New York
Vanda Investigational Site
Rochester, New York
Vanda Investigational Site
Staten Island, New York
Vanda Investigational Site
Cincinnati, Ohio
Vanda Investigational Site
Dayton, Ohio
Vanda Investigational Site
Portland, Oregon
Vanda Investigational Site
Lincoln, Rhode Island
Vanda Investigational Site
Memphis, Tennessee
Vanda Investigational Site
Austin, Texas
Vanda Investigational Site
Dallas, Texas
Vanda Investigational Site
Salt Lake City, Utah
Vanda Investigational Site
Seattle, Washington
Vanda Investigational Site
Brown Deer, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.